New Therapeutic System of Ruptured Intracranial Aneurysms Based on Big Data From Chinese Population
- Conditions
- Subarachnoid Hemorrhage, Aneurysmal
- Registration Number
- NCT03153748
- Lead Sponsor
- Changhai Hospital
- Brief Summary
This study aims at clarifying the current situation of Emergency treatment of aneurysmal subarachnoid hemorrhage (SAH) in China, and analyzing the safety and efficacy of the treatment strategy between interventional treatment and open surgery, so as to improve the diagnosis and treatment of aneurysmal SAH.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 10000
Inclusion Criteria
- patients presented with subarachnoid hemorrhage on CT or lumbar puncture.
- the intracranial hemorrhage was caused by rupture of aneurysm and was confirmed on CTA、MRA or DSA.
- patients willing to participate in this clinical trial and attach to regular follow up.
Exclusion Criteria
- intracranial aneurysm correlating to AVM.
- dissection, false, traumatic and infectious aneurysms.
- the rupture of the aneurysm can not be confirmed on CTA、MRA or DSA.
- patients unwilling to participate in this clinical trial and attach to regular follow up.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mRS score 1 year after treatment the mRS score after treatment
cure rate 6 months after treatment the proportion of the cured-patient according Raymond Class
- Secondary Outcome Measures
Name Time Method complication rate through study completion, an average of 1 year the proportion of complication happened after treatment including ischemic, hemorrhage, retreat, and so on
recurrence rate through study completion, an average of 1 year the proportion of the recurrence of the patient
Trial Locations
- Locations (1)
Changhai Hospital
🇨🇳Shanghai, Shanghai, China